Maxillofacial Plastic and Reconstructive Surgery

Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지

LANGERHANS CELL HISTIOCYTOSIS IN THE JUVENILE MANDIBLE

소아의 하악골을 침범한 랑거한스세포 조직구 증식증의 임상적 고찰

  • Kang, Yeon-Hee (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Park, Se-Hyun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Seo, Dong-Jun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Cha, In-Ho (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Yi, Choong-Kook (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Kim, Hyun-Sil (Oral Cancer Research Institute, College of Dentistry, Yonsei University) ;
  • Kim, Jin (Department of Oral Pathology, College of Dentistry, Yonsei University) ;
  • Kim, Hyung-Jun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University)
  • 강연희 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 박세현 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 서동준 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 차인호 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 이충국 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 김현실 (연세대학교 치과대학 구강종양연구소) ;
  • 김진 (연세대학교 치과대학 구강병리학교실) ;
  • 김형준 (연세대학교 치과대학 구강악안면외과학교실)
  • Published : 2008.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Langerhans cell histiocytosis (LCH) is characterized by proliferation of pathological Langerhans cells within different organs. It mainly affects children, but adult cases also occur, with an incidence rate of one to two per million. LCH results from the clonal proliferation of Langerhans cells. And its etiopathogenesis is still unknown. The hypothesis that it is a neoplastic or inflammatory disease, as well as the existence or not of immunological, viral or genetic predisposing factors, has been widely discussed in the literature, but no conclusive proof has ever been provided. Although lesions may appear in tissues of various origins such as skin, hypothalamus, liver, lung, or lymphoid tissue, bone is the most common site of the disease. The head and neck are affected in almost 90% of cases. The maxillary and mandibular bones are affected in 5 to 10% of cases. In our report, we present four cases of LCH in patients aged 3, 4, 7 and 9 years respectively, with primary manifestation in maxillofacial area.

Keywords

References

  1. Weitzman S, Egeler RM : Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr 20 : 23, 2008 https://doi.org/10.1097/MOP.0b013e3282f45ba4
  2. Campos MK, Viana MB, de Oliveira BM et al : Langerhans cell histiocytosis: a 16-year experience. J Pediatr (Rio J) 83 : 79, 2007 https://doi.org/10.2223/JPED.1581
  3. Osband ME : Histiocytosis X. Langerhans' cell histiocytosis. Hematol Oncol Clin North Am 1 : 737, 1987 https://doi.org/10.1016/S0889-8588(18)30650-6
  4. Hicks J, Flaitz CM : Langerhans cell histiocytosis: current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 : S42, 2005 https://doi.org/10.1016/j.tripleo.2005.06.016
  5. Margo CE, Goldman DR : Langerhans cell histiocytosis. Surv Ophthalmol 53 : 332, 2008 https://doi.org/10.1016/j.survophthal.2008.04.007
  6. Hoover KB, Rosenthal DI, Mankin H : Langerhans cell histiocytosis. Skeletal Radiol 36 : 95, 2007 https://doi.org/10.1007/s00256-006-0193-2
  7. Valdivielso M, Bueno C : [Langerhans cell histiocytosis]. Actas Dermosifiliogr 96 : 275, 2005 https://doi.org/10.1016/S0001-7310(05)75054-7
  8. Garcia de Marcos JA, Dean Ferrer A, Alamillos Granados F et al : Langerhans cell histiocytosis in the maxillofacial area in adults. Report of three cases. Med Oral Patol Oral Cir Bucal 12 : E145, 2007
  9. Satter EK, High WA : Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 25 : 291, 2008 https://doi.org/10.1111/j.1525-1470.2008.00669.x
  10. Hauser C : [The Langerhans cell histiocytoses]. J Dtsch Dermatol Ges 1 : 725, 2003 https://doi.org/10.1046/j.1610-0387.2003.03574.x
  11. Nquyen K, Tazi A : [Langerhans cell histiocytosis in adults]. Rev Prat 56 : 1863, 2006
  12. Greenberger JS, Crocker AC, Vawter G et al : Results of treatment of 127 patients with systemic histiocytosis. Medicine (Baltimore) 60 : 311, 1981 https://doi.org/10.1097/00005792-198109000-00001
  13. Bechan GI, Egeler RM, Arceci RJ : Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol 254 : 1, 2006 https://doi.org/10.1016/S0074-7696(06)54001-X
  14. Kim KY : Pediatric Oncology, 1 ed., Chang, Ju Young, 380, 1999
  15. Greenberger JS, Cassady JR, Jaffe N et al : Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys 5 : 1749, 1979 https://doi.org/10.1016/0360-3016(79)90556-X
  16. Chang KL, Snyder DS : Langerhans cell histiocytosis. Cancer Treat Res 142 : 383, 2008
  17. Osband ME, Pochedly C : Histiocytosis-X: an overview. Hematol Oncol Clin North Am 1 : 1, 1987 https://doi.org/10.1016/S0889-8588(18)30681-6
  18. Osband ME, Lipton JM, Lavin P et al : Histiocytosis-X. N Engl J Med 304:146, 1981 https://doi.org/10.1056/NEJM198101153040304